Meaning-Centered Psychotherapy in Advanced Cancer

This study has been completed.
Sponsor:
Information provided by:
National Center for Complementary and Alternative Medicine (NCCAM)
ClinicalTrials.gov Identifier:
NCT00067288
First received: August 14, 2003
Last updated: August 16, 2006
Last verified: August 2006

August 14, 2003
August 16, 2006
May 2002
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00067288 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Meaning-Centered Psychotherapy in Advanced Cancer
Meaning-Centered Psychotherapy in Advanced Cancer

We have developed an 8-week Meaning-Centered Group Psychotherapy designed to help patients with advanced cancer sustain or enhance a sense of meaning, peace and purpose despite the limitations of their cancer illness. This project's overall aim is to explore the feasibility and efficacy of this new and unique psychotherapy intervention for advanced cancer patients in enhancing psychological and spiritual well-being and quality of life by comparing it with a standard supportive group psychotherapy.

As per Brief Summary

Interventional
Phase 2
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Educational/Counseling/Training
  • Lymphoma, Non-Hodgkin
  • Neoplasms
  • Behavioral: Meaning-Centered Group Psychotherapy
  • Behavioral: Standard Supportive Group Psychotherapy
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
118
March 2006
Not Provided

Inclusion Criteria:

  • 21 years of age or older;
  • English speaking;
  • Stage III or IV solid-tumor or Non-Hodgkin's Lymphoma;
  • Receiving ambulatory care at Memorial Sloan-Kettering Cancer Center in New York City;

Exclusion Criteria:

  • Significant psychiatric disturbance sufficient, in the investigator's judgment, to preclude participation in a group-format intervention;
  • Presence of cognitive impairment disorder, such as delirium or dementia that is sufficient, in the investigator's opinion, to preclude meaningful participation and/or informed consent;
  • Karnofsky Performance Rating Scale below 50 or physical limitations or illness severity sufficient to preclude participation in outpatient group psychotherapy.
Both
21 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00067288
R21 AT001031-01, Breitbart
Not Provided
Not Provided
National Center for Complementary and Alternative Medicine (NCCAM)
Not Provided
Principal Investigator: William Breitbart, MD Memorial Sloan-Kettering Cancer Center
Investigator: Christopher Gibson, PhD Project Coordinator Memorial Sloan-Kettering Cancer Center
National Center for Complementary and Alternative Medicine (NCCAM)
August 2006

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP